Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2014 2
2015 3
2016 1
2017 4
2018 8
2019 6
2020 13
2021 12
2022 19
2023 15
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis.
Sala I, Pagan E, Pala L, Oriecuia C, Musca M, Specchia C, De Pas T, Cortes J, Giaccone G, Postow M, Gelber RD, Bagnardi V, Conforti F. Sala I, et al. Among authors: conforti f. Front Immunol. 2024 Jan 29;15:1340979. doi: 10.3389/fimmu.2024.1340979. eCollection 2024. Front Immunol. 2024. PMID: 38348030 Free PMC article.
"Heterogeneity of treatment effect on patients' long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer.".
Pala L, Sala I, Pagan E, De Pas T, Zattarin E, Catania C, Cocorocchio E, Rossi G, Laszlo D, Ceresoli G, Canzian J, Valenzi E, Bagnardi V, Conforti F. Pala L, et al. Among authors: conforti f. Breast. 2024 Feb;73:103672. doi: 10.1016/j.breast.2024.103672. Epub 2024 Jan 19. Breast. 2024. PMID: 38244459 Free PMC article.
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence: A Report From the Italian Sarcoma Group.
D'Ambrosio L, Fumagalli E, De Pas TM, Nannini M, Bertuzzi A, Carpano S, Boglione A, Buonadonna A, Comandini D, Gasperoni S, Vincenzi B, Brunello A, Badalamenti G, Maccaroni E, Baldi GG, Merlini A, Mogavero A, Ligorio F, Pennacchioli E, Conforti F, Manessi G, Aliberti S, Tolomeo F, Fiore M, Sbaraglia M, Dei Tos AP, Stacchiotti S, Pantaleo MA, Gronchi A, Grignani G; Italian Sarcoma Group. D'Ambrosio L, et al. Among authors: conforti f. JAMA Netw Open. 2023 Nov 1;6(11):e2341522. doi: 10.1001/jamanetworkopen.2023.41522. JAMA Netw Open. 2023. PMID: 37930700 Free PMC article.
Sex dimorphism and cancer immunotherapy: May pregnancy solve the puzzle?
Venanzi FM, Bini M, Nuccio A, De Toma A, Lambertini M, Ogliari FR, Oresti S, Viganò MG, Brioschi E, Polignano M, Naldini MM, Riva S, Ferrara M, Fogale N, Damiano G, Russo V, Reni M, Veronesi G, Foggetti G, Conforti F, Bulotta A, Ferrara R. Venanzi FM, et al. Among authors: conforti f. Cancer Treat Rev. 2023 Dec;121:102648. doi: 10.1016/j.ctrv.2023.102648. Epub 2023 Oct 26. Cancer Treat Rev. 2023. PMID: 37918169 Review.
The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high-volume referral centers.
Zagami P, Comandone A, Fiore M, Baldi GG, Grignani G, Vincenzi B, Gronchi A, Antonarelli G, Boglione A, Pennacchioli E, Curigliano G, Conforti F, De Pas TM. Zagami P, et al. Among authors: conforti f. Cancer Med. 2023 Aug;12(16):17047-17055. doi: 10.1002/cam4.6340. Epub 2023 Jul 16. Cancer Med. 2023. PMID: 37455549 Free PMC article.
Muscle and Muscle-like Autoantigen Expression in Myasthenia Gravis Thymus: Possible Molecular Hint for Autosensitization.
Iacomino N, Scandiffio L, Conforti F, Salvi E, Tarasco MC, Bortone F, Marcuzzo S, Simoncini O, Andreetta F, Pistillo D, Voulaz E, Alloisio M, Antozzi C, Mantegazza R, De Pas TM, Cavalcante P. Iacomino N, et al. Among authors: conforti f. Biomedicines. 2023 Feb 28;11(3):732. doi: 10.3390/biomedicines11030732. Biomedicines. 2023. PMID: 36979710 Free PMC article.
76 results